Ophthalmic medical device company AcuFocus, Inc. announced yesterday that the first US patient has been implanted with the IC-8 small aperture intraocular lens (IOL) as part of its pivotal study of the IC-8 lens in cataract patients. The company recently announced approval for an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration to conduct the study.

For more information: https://ic8lensclinicalstudy.com

Leave a Reply

Your email address will not be published. Required fields are marked *